Wesche Holger 4
4 · Harpoon Therapeutics, Inc. · Filed Feb 1, 2022
Insider Transaction Report
Form 4
Wesche Holger
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-01-28+135,000→ 135,000 totalExercise: $5.03Exp: 2032-01-27→ Common Stock (135,000 underlying)
Footnotes (1)
- [F1]1/48th of the total stock option will vest and become exercisable monthly on the same day of each month following the vesting commencement date of January 28, 2022, subject to the continuing employment of the Reporting Person on each vesting date.